Gilead shares fall after mixed results, as weaker COVID-19 drug remand weighs
April 27, 2023 at 17:18 PM EDT
Gilead Sciences Inc. on Thursday cut one of its profit forecasts and reported first-quarter profit that missed expectations.
Photography by Christophe Tomatis